Pfizer Inc. (ETR:PFE)
22.28
+0.39 (1.76%)
At close: Dec 5, 2025
Pfizer Revenue
Pfizer had revenue of $16.65B USD in the quarter ending September 28, 2025, a decrease of -5.92%. This brings the company's revenue in the last twelve months to $62.79B, up 3.89% year-over-year. In the year 2024, Pfizer had annual revenue of $63.63B with 6.84% growth.
Revenue (ttm)
$62.79B
Revenue Growth
+3.89%
P/S Ratio
2.37
Revenue / Employee
$775.12K
Employees
81,000
Market Cap
127.22B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 63.63B | 4.07B | 6.84% |
| Dec 31, 2023 | 59.55B | -41.62B | -41.14% |
| Dec 31, 2022 | 101.18B | 19.89B | 24.46% |
| Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
| Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck KGaA | 21.27B |
| Siemens Healthineers AG | 23.38B |
| Bayer Aktiengesellschaft | 45.87B |
| Fresenius SE & Co. KGaA | 22.45B |
| Sartorius Aktiengesellschaft | 3.52B |
| Fresenius Medical Care AG | 19.64B |
| Carl Zeiss Meditec AG | 2.18B |
| Fielmann Group AG | 2.42B |
Pfizer News
- 11 hours ago - Do These 3 Healthcare Stocks Need a Checkup? - The Motley Fool
- 15 hours ago - Smart Money Is Betting Big In PFE Options - Benzinga
- 17 hours ago - 2 Headwinds Facing Pfizer Stock Going Into 2026 - The Motley Fool
- 18 hours ago - Pfizer: The Market Is Still Wrong About It - Seeking Alpha
- 2 days ago - PFE June 2027 Options Begin Trading - Nasdaq
- 3 days ago - 17 dividend-stock bargains from a value manager with a stellar track record - Market Watch
- 3 days ago - Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock - Nasdaq
- 3 days ago - PFE: Citigroup Reinstates Neutral Rating with a $26 PT | PFE Stock News - GuruFocus